47 related articles for article (PubMed ID: 15578519)
1. BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level.
Helmke BM; Mollenhauer J; Herold-Mende C; Benner A; Thome M; Gassler N; Wahl W; Lyer S; Poustka A; Otto HF; Deichmann M
Gastroenterology; 2004 Dec; 127(6):1815-20. PubMed ID: 15578519
[TBL] [Abstract][Full Text] [Related]
2. Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases.
Deichmann M; Thome M; Benner A; Kirschner M; Hassanzadeh J; Kurzen H
BMC Cancer; 2005 Jun; 5():58. PubMed ID: 15935100
[TBL] [Abstract][Full Text] [Related]
3. Assessment of RAS-RAF-MAPK Pathway Mutation Status in Healthy Skin, Benign Nevi, and Cutaneous Melanomas: Pilot Study Using Droplet Digital PCR.
Dobre EG; Nichita L; Popp C; Zurac S; Neagu M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396984
[TBL] [Abstract][Full Text] [Related]
4. Metastatic Undifferentiated Melanoma Mimicking a Primary Bone Tumor: A Potential Diagnostic Pitfall.
Wills A; Dibbern M; Frierson HF; Raghavan SS
Am J Dermatopathol; 2024 Mar; 46(3):170-172. PubMed ID: 38170737
[TBL] [Abstract][Full Text] [Related]
5. A case of unknown primary melanoma detected with a BRAF gene mutation from a pleural fluid cell block.
Yamamoto S; Kuriyama H; Kashiwada-Nakamura K; Kajihara I; Makino K; Aoi J; Miyashita A; Yoshida C; Kubo Y; Fukushima S
J Dermatol; 2023 Sep; 50(9):e305-e306. PubMed ID: 37088959
[No Abstract] [Full Text] [Related]
6. Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment.
Sergi MC; Filoni E; Triggiano G; Cazzato G; Internò V; Porta C; Tucci M
Curr Oncol Rep; 2023 Nov; 25(11):1247-1258. PubMed ID: 37773078
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
[TBL] [Abstract][Full Text] [Related]
8. A Rare Case of Primary Anorectal Melanoma and a Review of the Current Landscape of Therapy.
Yeung HM; Gupta B; Kamat B
J Community Hosp Intern Med Perspect; 2020 Aug; 10(4):371-376. PubMed ID: 32850102
[TBL] [Abstract][Full Text] [Related]
9. Primary Malignant Anorectal Melanoma.
Huang WF; Wang X; Liu W
J Gastrointest Surg; 2022 Jan; 26(1):263-265. PubMed ID: 34506028
[No Abstract] [Full Text] [Related]
10. Incidence of
Dudin O; Mintser O; Kobyliak N; Kaminskyi D; Shabalkov R; Matvieieva A; Sukhanova O; Kalmykova A; Kozakov D; Mashukov A; Sulaieva O
Melanoma Manag; 2023 Mar; 10(1):MMT64. PubMed ID: 38221928
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters.
Catasus L; Gallardo A; Cuatrecasas M; Prat J
Mod Pathol; 2008 Feb; 21(2):131-9. PubMed ID: 18084252
[TBL] [Abstract][Full Text] [Related]
12. Recurrent R-spondin fusions in colon cancer.
Seshagiri S; Stawiski EW; Durinck S; Modrusan Z; Storm EE; Conboy CB; Chaudhuri S; Guan Y; Janakiraman V; Jaiswal BS; Guillory J; Ha C; Dijkgraaf GJ; Stinson J; Gnad F; Huntley MA; Degenhardt JD; Haverty PM; Bourgon R; Wang W; Koeppen H; Gentleman R; Starr TK; Zhang Z; Largaespada DA; Wu TD; de Sauvage FJ
Nature; 2012 Aug; 488(7413):660-4. PubMed ID: 22895193
[TBL] [Abstract][Full Text] [Related]
13. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.
Imielinski M; Berger AH; Hammerman PS; Hernandez B; Pugh TJ; Hodis E; Cho J; Suh J; Capelletti M; Sivachenko A; Sougnez C; Auclair D; Lawrence MS; Stojanov P; Cibulskis K; Choi K; de Waal L; Sharifnia T; Brooks A; Greulich H; Banerji S; Zander T; Seidel D; Leenders F; Ansén S; Ludwig C; Engel-Riedel W; Stoelben E; Wolf J; Goparju C; Thompson K; Winckler W; Kwiatkowski D; Johnson BE; Jänne PA; Miller VA; Pao W; Travis WD; Pass HI; Gabriel SB; Lander ES; Thomas RK; Garraway LA; Getz G; Meyerson M
Cell; 2012 Sep; 150(6):1107-20. PubMed ID: 22980975
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2.
Greulich H; Kaplan B; Mertins P; Chen TH; Tanaka KE; Yun CH; Zhang X; Lee SH; Cho J; Ambrogio L; Liao R; Imielinski M; Banerji S; Berger AH; Lawrence MS; Zhang J; Pho NH; Walker SR; Winckler W; Getz G; Frank D; Hahn WC; Eck MJ; Mani DR; Jaffe JD; Carr SA; Wong KK; Meyerson M
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14476-81. PubMed ID: 22908275
[TBL] [Abstract][Full Text] [Related]
15. Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine.
Smith G; Bounds R; Wolf H; Steele RJ; Carey FA; Wolf CR
Br J Cancer; 2010 Feb; 102(4):693-703. PubMed ID: 20147967
[TBL] [Abstract][Full Text] [Related]
16. Double EGFR mutants containing rare EGFR mutant types show reduced in vitro response to gefitinib compared with common activating missense mutations.
Tam IY; Leung EL; Tin VP; Chua DT; Sihoe AD; Cheng LC; Chung LP; Wong MP
Mol Cancer Ther; 2009 Aug; 8(8):2142-51. PubMed ID: 19671738
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations affect key pathways in lung adenocarcinoma.
Ding L; Getz G; Wheeler DA; Mardis ER; McLellan MD; Cibulskis K; Sougnez C; Greulich H; Muzny DM; Morgan MB; Fulton L; Fulton RS; Zhang Q; Wendl MC; Lawrence MS; Larson DE; Chen K; Dooling DJ; Sabo A; Hawes AC; Shen H; Jhangiani SN; Lewis LR; Hall O; Zhu Y; Mathew T; Ren Y; Yao J; Scherer SE; Clerc K; Metcalf GA; Ng B; Milosavljevic A; Gonzalez-Garay ML; Osborne JR; Meyer R; Shi X; Tang Y; Koboldt DC; Lin L; Abbott R; Miner TL; Pohl C; Fewell G; Haipek C; Schmidt H; Dunford-Shore BH; Kraja A; Crosby SD; Sawyer CS; Vickery T; Sander S; Robinson J; Winckler W; Baldwin J; Chirieac LR; Dutt A; Fennell T; Hanna M; Johnson BE; Onofrio RC; Thomas RK; Tonon G; Weir BA; Zhao X; Ziaugra L; Zody MC; Giordano T; Orringer MB; Roth JA; Spitz MR; Wistuba II; Ozenberger B; Good PJ; Chang AC; Beer DG; Watson MA; Ladanyi M; Broderick S; Yoshizawa A; Travis WD; Pao W; Province MA; Weinstock GM; Varmus HE; Gabriel SB; Lander ES; Gibbs RA; Meyerson M; Wilson RK
Nature; 2008 Oct; 455(7216):1069-75. PubMed ID: 18948947
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of cancer-associated EGFR mutants using a cellular assay with YFP-tagged EGFR intracellular domain.
de Gunst MM; Gallegos-Ruiz MI; Giaccone G; Rodriguez JA
Mol Cancer; 2007 Sep; 6():56. PubMed ID: 17877814
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.
Lee JC; Vivanco I; Beroukhim R; Huang JH; Feng WL; DeBiasi RM; Yoshimoto K; King JC; Nghiemphu P; Yuza Y; Xu Q; Greulich H; Thomas RK; Paez JG; Peck TC; Linhart DJ; Glatt KA; Getz G; Onofrio R; Ziaugra L; Levine RL; Gabriel S; Kawaguchi T; O'Neill K; Khan H; Liau LM; Nelson SF; Rao PN; Mischel P; Pieper RO; Cloughesy T; Leahy DJ; Sellers WR; Sawyers CL; Meyerson M; Mellinghoff IK
PLoS Med; 2006 Dec; 3(12):e485. PubMed ID: 17177598
[TBL] [Abstract][Full Text] [Related]
20. Complex mutation patterns of epidermal growth factor receptor gene associated with variable responses to gefitinib treatment in patients with non-small cell lung cancer.
Hsieh MH; Fang YF; Chang WC; Kuo HP; Lin SY; Liu HP; Liu CL; Chen HC; Ku YC; Chen YT; Chang YH; Chen YT; Hsi BL; Tsai SF; Huang SF
Lung Cancer; 2006 Sep; 53(3):311-22. PubMed ID: 16870303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
